webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

Bis-PEG25-NHS ester

  CAS No.: 2221948-96-3   Cat No.: BADC-01081   Purity: >98.0% 4.5  

Bis-PEG25-NHS ester features a long PEG spacer with dual NHS esters, widely used in ADC linker design for hydrophilic and flexible bioconjugation. This linker improves solubility and reduces aggregation, enhancing the therapeutic index of antibody-drug conjugates.

Bis-PEG25-NHS ester

Structure of 2221948-96-3

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C14H16N2O10
Molecular Weight
372.28
Shipping
Room temperature
Shipping
-20°C

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Synonyms
NHS-PEG24-NHS
IUPAC Name
(2,5-dioxopyrrolidin-1-yl) 3-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[3-(2,5-dioxopyrrolidin-1-yl)oxy-3-oxopropoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]propanoate
Canonical SMILES
C1CC(=O)N(C1=O)OC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCC(=O)ON2C(=O)CCC2=O
InChI
InChI=1S/C62H112N2O33/c65-57-1-2-58(66)63(57)96-61(69)5-7-71-9-11-73-13-15-75-17-19-77-21-23-79-25-27-81-29-31-83-33-35-85-37-39-87-41-43-89-45-47-91-49-51-93-53-55-95-56-54-94-52-50-92-48-46-90-44-42-88-40-38-86-36-34-84-32-30-82-28-26-80-24-22-78-20-18-76-16-14-74-12-10-72-8-6-62(70)97-64-59(67)3-4-60(64)68/h1-56H2
InChIKey
JPTYKIPGEDAOCK-UHFFFAOYSA-N
Solubility
10 mm in DMSO
Appearance
Solid
Shelf Life
-20°C 3 years powder; -80°C 2 years in solvent
Shipping
Room temperature
Storage
-20°C
Form
Solid

Bis-PEG25-NHS ester, a multifaceted bifunctional polyethylene glycol (PEG) derivative, boasts extensive applications in bioconjugation and cross-linking. Dive into four key applications of Bis-PEG25-NHS ester presented with a high degree of perplexity and burstiness:

Protein Modification: Through the strategic utilization of Bis-PEG25-NHS ester, researchers can intricately modify proteins via PEGylation, a sophisticated process entailing the attachment of PEG chains. These intricately intertwined chains not only augment the solubility, stability, and biocompatibility of proteins but also mitigate immunogenicity and proteolytic degradation. This cutting-edge technique serves as a cornerstone in the realm of protein-based drugs and therapeutic enzymes, heralding a new era of advanced therapeutic formulations.

Nanoparticle Surface Functionalization: Serving as a linchpin in the functionalization of nanoparticle surfaces, Bis-PEG25-NHS ester plays a critical role in enhancing their dispersibility and stability within biological environments. Surface modification with PEG chains serves to minimize nonspecific interactions and extend circulation time in the bloodstream, a pivotal factor in the efficient delivery of drugs and imaging agents in the burgeoning field of nanomedicine.

Hydrogel Formation: In the domain of biomaterials, Bis-PEG25-NHS ester emerges as a pivotal player in the synthesis of hydrogels by intricately cross-linking polymer chains. These meticulously crafted hydrogels, finely tuned through the cross-linking process, exhibit tailored mechanical properties and biocompatibility, rendering them ideal for a myriad of biomedical applications, including tissue engineering and wound healing. The meticulous control over cross-linking endows researchers with the ability to customize the physical attributes of the hydrogel for optimized performance.

Biosensor Development: Within the intricate realm of biosensor technology, Bis-PEG25-NHS ester assumes a critical role in immobilizing biomolecules such as antibodies and enzymes onto sensor surfaces. The resultant PEGylated surfaces exhibit remarkable resistance to protein adsorption, thereby diminishing background noise and amplifying sensor specificity. This groundbreaking advancement translates into heightened accuracy and reliability in detecting analytes, indispensable for diagnostic assays and environmental monitoring endeavors.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker/Peptide Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker/Hydrazone Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: Bis-PEG4-NHS ester | bis-PEG2-endo-BCN | Bis-PEG9-acid | Bis-PEG17-NHS ester | PDM3 | Norbornene-NHS | Norbornene-methyl-NHS | Bis-PEG7-acid | Bis-PEG10-NHS ester | Bis-PEG13-NHS ester | Bis-PEG25-NHS ester
Send Inquiry
Verification code
Inquiry Basket